These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

627 related items for PubMed ID: 11343250

  • 21. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
    Hillaire S, Ballet F, Franco D, Setchell KD, Poupon R.
    Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Functional and ultrastructural features of ethanol/bile salts interaction in the isolated perfused rat liver.
    Alvaro D, Benedetti A, Gigliozzi A, Bini A, Della Guardia P, La Rosa T, Jezequel AM, Capocaccia L.
    Hepatology; 1995 Apr; 21(4):1120-9. PubMed ID: 7705787
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion.
    Fiorotto R, Spirlì C, Fabris L, Cadamuro M, Okolicsanyi L, Strazzabosco M.
    Gastroenterology; 2007 Nov; 133(5):1603-13. PubMed ID: 17983806
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Genipin enhances Mrp2 (Abcc2)-mediated bile formation and organic anion transport in rat liver.
    Shoda J, Miura T, Utsunomiya H, Oda K, Yamamoto M, Kano M, Ikegami T, Tanaka N, Akita H, Ito K, Suzuki H, Sugiyama Y.
    Hepatology; 2004 Jan; 39(1):167-78. PubMed ID: 14752835
    [Abstract] [Full Text] [Related]

  • 31. Taurohyodeoxycholic acid protects against taurochenodeoxycholic acid-induced cholestasis in the rat.
    Roda A, Piazza F, Baraldini M, Speroni E, Guerra MC, Cerré C, Cantelli Forti G.
    Hepatology; 1998 Feb; 27(2):520-5. PubMed ID: 9462652
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Long-term effect of treating pregnant rats with ursodeoxycholic acid on the congenital impairment of bile secretion induced in the pups by maternal cholestasis.
    Macias RI, Serrano MA, Monte MJ, Jimenez S, Hernandez B, Marin JJ.
    J Pharmacol Exp Ther; 2005 Feb; 312(2):751-8. PubMed ID: 15452192
    [Abstract] [Full Text] [Related]

  • 34. Protein kinase C-dependent distribution of the multidrug resistance protein 2 from the canalicular to the basolateral membrane in human HepG2 cells.
    Kubitz R, Huth C, Schmitt M, Horbach A, Kullak-Ublick G, Häussinger D.
    Hepatology; 2001 Aug; 34(2):340-50. PubMed ID: 11481619
    [Abstract] [Full Text] [Related]

  • 35. Differential effects of hydroxyacetophenone analogues on the transcytotic vesicular pathway in rat liver.
    Tradtrantip L, Boyer JL, Suksamrarn A, Piyachaturawat P.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):152-9. PubMed ID: 16945364
    [Abstract] [Full Text] [Related]

  • 36. Insulin inhibits secretin-induced ductal secretion by activation of PKC alpha and inhibition of PKA activity.
    Lesage GD, Marucci L, Alvaro D, Glaser SS, Benedetti A, Marzioni M, Patel T, Francis H, Phinizy JL, Alpini G.
    Hepatology; 2002 Sep 10; 36(3):641-51. PubMed ID: 12198656
    [Abstract] [Full Text] [Related]

  • 37. Structural and functional alterations of hepatocytes during transient phalloidin-induced cholestasis in the rat.
    Loranger A, Barriault C, Yousef IM, Tuchweber B.
    Toxicol Appl Pharmacol; 1996 Mar 10; 137(1):100-11. PubMed ID: 8607135
    [Abstract] [Full Text] [Related]

  • 38. Tauroursodeoxycholic acid mobilizes alpha-PKC after uptake in human HepG2 hepatoma cells.
    Glasova H, Berghaus TM, Kullak-Ublick GA, Paumgartner G, Beuers U.
    Eur J Clin Invest; 2002 Jun 10; 32(6):437-42. PubMed ID: 12059989
    [Abstract] [Full Text] [Related]

  • 39. Reduced cholestatic potency of taurolithocholate during backward perfusion of the rat liver.
    Baumgartner U, Hardison WG, Miyai K.
    Lab Invest; 1987 Jun 10; 56(6):576-82. PubMed ID: 3599905
    [Abstract] [Full Text] [Related]

  • 40. Hepatic sequestration and modulation of the canalicular transport of the organic cation, daunorubicin, in the Rat.
    Hayes JH, Soroka CJ, Rios-Velez L, Boyer JL.
    Hepatology; 1999 Feb 10; 29(2):483-93. PubMed ID: 9918926
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.